Authors: Manning, M Stoev, S Cheng, LL Wo, NC Chan, WY

Citation: M. Manning et al., Design of oxytocin antagonists, which are more selective than Atosiban, J PEPT SCI, 7(9), 2001, pp. 449-465

Authors: Chan, WY Levi, R Wo, NC Koyama, M Stoev, S Cheng, LL Manning, M

Citation: Wy. Chan et al., Novel selective hypotensive vasopressin peptides: cardiovascular and structure-activity-relationship studies, EUR J PHARM, 419(1), 2001, pp. 65-72

Authors: Chan, WY Wo, NC Stoev, S Cheng, LL Manning, M

Citation: Wy. Chan et al., Discovery and design of novel and selective vasopressin and oxytocin agonists and antagonists: the role of bioassays, EXP PHYSIOL, 85, 2000, pp. 7S-18S

Authors: Manning, M Stoev, S Cheng, LL Wo, NC Chan, WY

Citation: M. Manning et al., Discovery and design of novel vasopressin hypotensive peptide agonists, J RECEPT SI, 19(1-4), 1999, pp. 631-644

Authors: Stoev, S Cheng, LL Olma, A Klis, WA Manning, M Sawyer, WH Wo, NC Chan, WY

Citation: S. Stoev et al., An investigation of position 3 in arginine vasopressin with aliphatic, aromatic, conformationally-restricted, polar and charged amino acids, J PEPT SCI, 5(3), 1999, pp. 141-153

Authors: Manning, M Stoev, S Cheng, LL Wo, NC Chan, WY

Citation: M. Manning et al., Synthesis and structure-activity investigation of novel vasopressin hypotensive peptide agonists, J PEPT SCI, 5(11), 1999, pp. 472-490